Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Antitumor activity of an interleukin-2 monoclonal antibody in a murine osteosarcoma transplantation model.

Kohyama K, Sugiura H, Kozawa E, Wasa J, Yamada K, Nishioka A, Kamei Y, Taguchi O.

Anticancer Res. 2012 Mar;32(3):779-82.

PMID:
22399592
2.

Decorin suppresses lung metastases of murine osteosarcoma.

Shintani K, Matsumine A, Kusuzaki K, Morikawa J, Matsubara T, Wakabayashi T, Araki K, Satonaka H, Wakabayashi H, Iino T, Uchida A.

Oncol Rep. 2008 Jun;19(6):1533-9.

PMID:
18497961
3.

Suppression of tumour metastasis in a murine osteosarcoma model with anti-CD25 monoclonal antibody treatment.

Kozawa E, Sugiura H, Wasa J, Kohyama K, Yamada K, Nishioka A, Nishida Y, Ishiguro N, Taguchi O.

Anticancer Res. 2010 Dec;30(12):5019-22.

PMID:
21187484
4.

Immunotherapy with interleukin-18 in combination with preoperative chemotherapy with ifosfamide effectively inhibits postoperative progression of pulmonary metastases in a mouse osteosarcoma model.

Yamada N, Hata M, Ohyama H, Yamanegi K, Kogoe N, Nakasho K, Futani H, Okamura H, Terada N.

Tumour Biol. 2009;30(4):176-84. doi: 10.1159/000236410.

PMID:
19738413
5.

Anti-TGF-β antibody combined with dendritic cells produce antitumor effects in osteosarcoma.

Kawano M, Itonaga I, Iwasaki T, Tsuchiya H, Tsumura H.

Clin Orthop Relat Res. 2012 Aug;470(8):2288-94. doi: 10.1007/s11999-012-2299-2.

6.

Effect of interleukin-18 on metastasis of mouse osteosarcoma cells.

Nakamura Y, Yamada N, Ohyama H, Nakasho K, Nishizawa Y, Okamoto T, Futani H, Yoshiya S, Okamura H, Terada N.

Cancer Immunol Immunother. 2006 Sep;55(9):1151-8.

PMID:
16408211
7.

Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.

Pan H, Lu HM, Hu WM, Tian BL, Liu XB, Zhang ZD, Mai G.

Transplant Proc. 2007 Dec;39(10):3452-4.

PMID:
18089405
8.

Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases.

Ciolli V, Gabriele L, Sestili P, Varano F, Proietti E, Gresser I, Testa U, Montesoro E, Bulgarini D, Mariani G, et al.

J Exp Med. 1991 Feb 1;173(2):313-22.

9.

Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses.

Griffith TS, Kawakita M, Tian J, Ritchey J, Tartaglia J, Sehgal I, Thompson TC, Zhao W, Ratliff TL.

J Natl Cancer Inst. 2001 Jul 4;93(13):998-1007.

10.

Adjuvant effect of a Flt3 ligand (FL) gene-transduced xenogeneic cell line in a murine colon cancer model.

Kim EM, Sivanandham M, Stavropoulos CI, Wallack MK.

J Surg Res. 2002 Nov;108(1):148-56.

PMID:
12443727
12.

Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma.

Kawano M, Nishida H, Nakamoto Y, Tsumura H, Tsuchiya H.

Clin Orthop Relat Res. 2010 May;468(5):1373-83. doi: 10.1007/s11999-010-1302-z.

13.

In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy.

Tomala J, Chmelova H, Mrkvan T, Rihova B, Kovar M.

J Immunol. 2009 Oct 15;183(8):4904-12. doi: 10.4049/jimmunol.0900284.

14.

IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb.

Kamimura D, Sawa Y, Sato M, Agung E, Hirano T, Murakami M.

J Immunol. 2006 Jul 1;177(1):306-14.

15.

Survival of mice with metastatic osteosarcoma treated by cyclophosphamide or radiotherapy.

Shaeffer J, El-Mahdi AM, Constable WC.

Cancer Res. 1975 Dec;35(12):3596-8.

16.

A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.

Weiner LM, Holmes M, Adams GP, LaCreta F, Watts P, Garcia de Palazzo I.

Cancer Res. 1993 Jan 1;53(1):94-100.

17.

[Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].

Kong B, Wang W, Liu C, Ma D, Qu X, Jiang J, Yang X, Zhang Y, Jiang S.

Zhonghua Yi Xue Za Zhi. 2002 Sep 10;82(17):1207-10. Chinese.

PMID:
12475412
18.

Attenuated Salmonella typhimurium with IL-2 gene reduces pulmonary metastases in murine osteosarcoma.

Sorenson BS, Banton KL, Frykman NL, Leonard AS, Saltzman DA.

Clin Orthop Relat Res. 2008 Jun;466(6):1285-91. doi: 10.1007/s11999-008-0243-2.

19.

Interleukin-2 blocks the antitumour activity caused by depletion of CD25 cells in a murine renal adenocarcinoma model.

Takeuchi T, Konno-Takahashi N, Kasuya Y, Ogushi T, Nishimatsu H, Kitamura T.

BJU Int. 2004 Jul;94(1):171-6.

20.

Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma.

Nishimura A, Akeda K, Matsubara T, Kusuzaki K, Matsumine A, Masuda K, Gemba T, Uchida A, Sudo A.

Cancer Gene Ther. 2011 Apr;18(4):250-9. doi: 10.1038/cgt.2010.75.

PMID:
21183950
Items per page

Supplemental Content

Support Center